Actively Recruiting
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Led by University Hospital, Clermont-Ferrand · Updated on 2025-05-28
5000
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Clermont-Ferrand
Lead Sponsor
I
I-SITE Cap 20-25 project
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
CONDITIONS
Official Title
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Man or woman aged 18 to 90.
- Patients with chronic pathology contributing to impaired mobility.
- Volunteers who have given their written consent.
- Affiliated to French health care system (for France)
You will not qualify if you...
- Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).
- People with poorly controlled or unstable cardiovascular disease.
- Major osteoarticular or neurological problems completely preventing proper performance of the various tests.
- Non-autonomous patient.
- Persons under guardianship, curatorship, deprived of liberty, or safeguarding justice.
- People excluded from another study.
- Pregnant or lactating women.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Clermont Ferrand
Clermont-Ferrand, France, 63003
Actively Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here